• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Humacyte, Inc. - Common Stock (NQ:HUMA)

    0.6927 +0.0111 (+1.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,903,923
    Open 0.7000
    Bid (Size) 0.6915 (100)
    Ask (Size) 0.7080 (600)
    Prev. Close 0.6816
    Today's Range 0.6870 - 0.7082
    52wk Range 0.5261 - 2.550
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Humacyte (HUMA) Q2 2026 Earnings Call Transcript ↗
    Phase III trial shows 91 more catheter-free days for dialysis patients. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Humacyte Q2 Earnings Call Highlights ↗
    Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    -29.0%
    -29.0%
    1 Month
    +2.8%
    +2.8%
    3 Month
    -39.8%
    -39.8%
    6 Month
    -40.3%
    -40.3%
    1 Year
    -52.9%
    -52.9%

    More News

    Read More
    News headline image
    Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Humacyte Inc (NASDAQ:HUMA) Reports Q4 Revenue Miss, Shares Drop Pre-Market ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 12, 2025 ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now
    Via AB Newswire
    Topics Artificial Intelligence
    MissionIRNewsBreaks – Humacyte Inc. (NASDAQ: HUMA) Prices $50 Million Public Offering
    Via Investor Brand Network
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Humacyte (HUMA) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Humacyte (HUMA) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Humacyte Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    The market is filled with gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
    Via Stocktwits
    News headline image
    Humacyte (HUMA) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Death Earnings
    News headline image
    Humacyte Inc (NASDAQ:HUMA) Beats on EPS but Misses on Revenue in Q3 ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Insights Ahead: Humacyte's Quarterly Earnings ↗
    Via Benzinga
    BioMedNewsBreaks — Humacyte, Inc. (NASDAQ: HUMA) Announces $60 Million Registered Direct Offering of Common Stock and Warrants
    Via Investor Brand Network
    News headline image
    D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
    Via ACCESS Newswire
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Humacyte, Inc. - Common Stock publicly traded?
    Yes, Humacyte, Inc. - Common Stock is publicly traded.
    What exchange does Humacyte, Inc. - Common Stock trade on?
    Humacyte, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Humacyte, Inc. - Common Stock?
    The ticker symbol for Humacyte, Inc. - Common Stock is HUMA on the Nasdaq Stock Market
    What is the current price of Humacyte, Inc. - Common Stock?
    The current price of Humacyte, Inc. - Common Stock is 0.6927
    When was Humacyte, Inc. - Common Stock last traded?
    The last trade of Humacyte, Inc. - Common Stock was at 08/27/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.